Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Denali Therapeutics Inc.

After Hours

 --Quotes are delayed by 20 min

Jan 27, 2023, 6:16 p.m.

DNLI
/zigman2/quotes/200043077/composite

$

32.00

Change

+0.53 +1.68%

Volume

Volume 8,205

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Previous close

$ 30.53

$ 31.47

Change

+0.94 +3.08%

Day low

Day high

$30.53

$31.98

Open

52 week low

52 week high

$20.24

$39.43

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Denali Therapeutics Inc.

View Ratios
Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -129.16M26.68M335.66M48.66M
Cost of Goods Sold (COGS) incl. D&A 3.08M---5.61M
COGS excluding D&A -----
Depreciation & Amortization Expense 3.08M7.42M7.99M6.17M5.61M
Depreciation 3.08M7.42M7.99M6.17M5.61M
Amortization of Intangibles -----
Gross Income (3.08M)---43.05M
20172018201920202021 5-year trend
SG&A Expense 87.06M160.22M230.37M266.77M338.8M
Research & Development 71.38M135.28M191.88M212.62M265.35M
Other SG&A 15.68M24.93M38.49M54.16M-
Other Operating Expense -----
Unusual Expense -8.1M1.3M(100,000)-
EBIT after Unusual Expense -(46.57M)(212.98M)62.82M-
Non Operating Income/Expense -----
Non-Operating Interest Income 1.96M10.33M15.02M9.14M4.6M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (88.19M)(36.24M)(197.97M)71.96M(291.16M)
Income Tax --(351,000)823,000(575,000)
Income Tax - Current Domestic ---823,000(576,000)
Income Tax - Current Foreign ----1,000
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (88.19M)(36.24M)(197.61M)71.14M(290.58M)
Minority Interest Expense -----
Net Income (88.19M)(36.24M)(197.61M)71.14M(290.58M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (88.19M)(36.24M)(197.61M)71.14M(290.58M)
Preferred Dividends -----
Net Income Available to Common (88.19M)(36.24M)(197.61M)71.14M(290.58M)
EPS (Basic) (5.89)(0.39)(2.07)0.65(2.39)
Basic Shares Outstanding 14.96M92.62M95.61M108.97M121.52M
EPS (Diluted) (5.89)(0.39)(2.07)0.63(2.39)
Diluted Shares Outstanding 14.96M92.62M95.61M112.7M121.52M
EBITDA (87.06M)(31.06M)(203.69M)68.89M(290.14M)
Copyright 2023 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.